Epidemiology and etiology of meningioma.
Although most meningiomas are encapsulated and benign tumors with limited numbers of genetic aberrations, their intracranial location often leads to serious and potentially lethal consequences. They are the most frequently diagnosed primary brain tumor accounting for 33.8% of all primary brain and central nervous system tumors reported in the United States between 2002 and 2006. Inherited susceptibility to meningioma is suggested both by family history and candidate gene studies in DNA repair genes. People with certain mutations in the neurofibromatosis gene (NF2) have a very substantial increased risk for meningioma. High dose ionizing radiation exposure is an established risk factor for meningioma, and lower doses may also increase risk, but which types and doses are controversial or understudied. Because women are twice as likely as men to develop meningiomas and these tumors harbor hormone receptors, an etiologic role for hormones (both endogenous and exogenous) has been hypothesized. The extent to which immunologic factors influence meningioma etiology has been largely unexplored. Growing emphasis on brain tumor research coupled with the advent of new genetic and molecular epidemiologic tools in genetic and molecular epidemiology promise hope for advancing knowledge about the causes of intra-cranial meningioma. In this review, we highlight current knowledge about meningioma epidemiology and etiology and suggest future research directions.
Wiemels
Joseph
J
Department of Epidemiology and Biostatistics, University of California San Francisco, Helen Diller Cancer Research Building, MC 0520, San Francisco, CA 94158, USA. joe.wiemels@ucsf.edu
Wrensch
Margaret
M
Claus
Elizabeth B
EB
D006801:Humans; D008577:Meningeal Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D008579:Meningioma / Q000453:epidemiology* / Q000209:etiology*
Int J Cancer. 2003 Aug 20;106(2):260-3
12800203
Cancer Genet Cytogenet. 1987 May;26(1):127-41
3470128
Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-95
16331155
Cancer. 2004 Mar 1;100(5):1026-34
14983499
Int J Cancer. 2006 Sep 1;119(5):1152-7
16570277
Int J Cancer. 2002 May 10;99(2):252-9
11979441
J Neurosurg. 1997 Jan;86(1):113-20
8988089
Cancer. 2007 Aug 1;110(3):471-6
17580362
N Engl J Med. 2001 Jan 11;344(2):79-86
11150357
Neurology. 2002 Jun 25;58(12):1849-52
12084890
J Natl Cancer Inst. 2002 Oct 16;94(20):1555-63
12381708
Childs Nerv Syst. 2009 Nov;25(11):1411-7
19636568
Eur J Cancer B Oral Oncol. 1992 Oct;28B(2):91-5
1306734
Surg Neurol. 2005 Jun;63(6):550-3; discussion 553
15936382
Br J Cancer. 2008 Jul 8;99(1):185-90
18560401
Am J Epidemiol. 2006 Oct 1;164(7):629-36
16835295
J Natl Cancer Inst. 2008 Feb 20;100(4):270-6
18270339
Neurosurgery. 2007 May;60(5):787-98; discussion 787-98
17460514
J Neurosurg. 2002 Nov;97(5):1078-82
12450029
J Natl Cancer Inst. 2001 Feb 7;93(3):203-7
11158188
N Engl J Med. 1988 Oct 20;319(16):1033-9
3173432
Neuro Oncol. 2009 Aug;11(4):414-22
19001526
Acta Neurochir Suppl. 1996;65:50-3
8738495
J Neurosurg. 2003 Nov;99(5):848-53
14609164
JAMA. 2000 Dec 20;284(23):3001-7
11122586
Lancet Oncol. 2009 May;10(5):481-8
19356978
Neuroepidemiology. 1990;9(2):106-11
2333123
Acta Neurochir (Wien). 2009 Mar;151(3):239-44; discussion 244
19238320
J Neurosurg. 2010 May;112(5):920-4
19731987
Brain Pathol. 2010 Jul;20(4):751-62
20015288
Lancet Neurol. 2006 Dec;5(12):1045-54
17110285
Am J Epidemiol. 2007 Mar 1;165(5):477-85
17182979
Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1784-90
16030117
JAMA. 2007 Mar 21;297(11):1207-15
17374815
Cancer. 1992 May 15;69(10):2541-7
1568177
J Neurosurg. 1993 Mar;78(3):456-62
8433149
Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1655-61
17684142
Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70
18843008
J Natl Cancer Inst. 2007 Oct 17;99(20):1544-50
17925535
J Clin Oncol. 2008 Jan 10;26(2):279-82
18182668
Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1356-61
20406964
Cancer Res. 2008 Jan 1;68(1):314-22
18172325
Ann Epidemiol. 2009 Mar;19(3):161-71
19216998
J Neurooncol. 2006 Oct;80(1):1-7
16703453
J Natl Cancer Inst. 2006 Nov 1;98(21):1528-37
17077355
BMC Cancer. 2006 Jun 07;6:152
16759391
Am J Epidemiol. 2007 Oct 15;166(8):941-50
17646205
Eur J Epidemiol. 2009;24(8):433-40
19484497
Am J Epidemiol. 2000 Feb 1;151(3):266-72
10670551
Int J Epidemiol. 2010 Jun;39(3):675-94
20483835
J Neurooncol. 2007 May;82(3):229-37
17151932
N Engl J Med. 2007 Nov 1;357(18):1821-8
17978290
Cancer. 2002 Mar 15;94(6):1626-35
11920521
Cancer Causes Control. 1998 Jan;9(1):109-16
9486470
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):969-76
15824172
Cancer. 2004 Mar 15;100(6):1208-12
15022288
BMC Genomics. 2007 Jan 12;8:16
17222329
J Natl Cancer Inst. 1980 Jul;65(1):67-73
6930521
Int J Cancer. 1997 Jul 29;72(3):389-93
9247278
Neurosurgery. 1979 Mar;4(3):203-6
460549
Neurosurg Focus. 2005 Nov 15;19(5):E9
16398473
BMC Med Genomics. 2009 Jul 09;2:42
19589153